MCAT content library / Biology & biochemistry / Blood cells and clotting
Distinguish a concentration change from a cell-mass change, then localize a hemostatic defect to platelets or the fibrin-forming cascade.
About 17 minutes, including the hematocrit calculation and simplified clotting pathway.
Useful foundations
On this page
- Hematocrit is a fraction, not a cell count
- Concept: red-cell mass reflects production and removal
- Worked application: plasma loss changes the ratio
- Pattern: primary and secondary hemostasis answer different questions
- Application: localize a block in a supplied coagulation cascade
- Check your reasoning
- Continue learning
- Sources
Hematocrit is a fraction, not a cell count
Blood contains plasma plus formed elements, including erythrocytes, leukocytes, and platelets. Hematocrit is the fraction of blood volume occupied by red blood cells. It can change because red-cell volume changes, plasma volume changes, or both.2
This matters when interpreting dehydration or fluid loading. A higher hematocrit does not automatically mean that new red cells were produced; a fall in plasma volume can increase the fraction even when total red-cell mass is unchanged.
Concept: red-cell mass reflects production and removal
Adult red blood cells are generated from bone-marrow precursors. Erythropoietin, produced mainly by the kidneys, promotes erythropoiesis. Mature erythrocytes lack nuclei and most organelles and cannot divide; their population must therefore be maintained by ongoing production. Senescent red cells are removed largely by macrophages in the spleen and liver, with a typical human red-cell lifespan of roughly 120 days.3
A falling red-cell count can therefore reflect reduced production, increased loss, or increased destruction. Hematocrit alone does not tell you which process changed.
Worked application: plasma loss changes the ratio
An original blood-volume model begins with 2.0 L of packed red-cell volume and 3.0 L of plasma, for 5.0 L total blood volume. The initial hematocrit is:
2.0 / 5.0 = 0.40, or 40%.
A short-term fluid loss removes 0.5 L of plasma but, for this model, changes neither red-cell number nor red-cell volume. Total blood volume becomes 4.5 L while red-cell volume remains 2.0 L.
| Condition | RBC volume | Plasma volume | Hematocrit |
|---|---|---|---|
| Initial | 2.0 L | 3.0 L | 40.0% |
| After isolated 0.5-L plasma loss | 2.0 L | 2.5 L | 44.4% |
This is a concentration effect. A later physiological response could alter erythropoiesis, but that would occur on a different timescale and should not be inferred from the immediate ratio change.
Pattern: primary and secondary hemostasis answer different questions
Hemostasis begins after vascular injury. Platelet adhesion, activation, and aggregation build a temporary platelet plug—often called primary hemostasis. Coagulation reactions generate thrombin and fibrin, which stabilize that plug—secondary hemostasis.4
A platelet defect can therefore impair the initial plug even when soluble coagulation factors are intact. A coagulation-factor defect can permit platelet aggregation but leave the plug poorly reinforced by fibrin. “Clotting” is the integrated outcome of both processes, so the experiment must specify which readout failed.
Application: localize a block in a supplied coagulation cascade
An original simplified cascade is supplied:
Protease X activates protease Y → Y converts proenzyme Z to enzyme Z* → Z* converts soluble fibrinogen to fibrin.
Platelet aggregation is measured separately and is normal in every sample. Three plasma preparations are tested:
| Sample | Y activity | Z* activity | Fibrin formation |
|---|---|---|---|
| Control | + | + | + |
| Sample A | − | − | − |
| Sample B | + | − | − |
| Sample C | + | + | − |
Sample A is consistent with a defect at X or earlier because Y never becomes active. Sample B localizes the defect between active Y and active Z*. Sample C reaches active Z* but still fails to make fibrin, so the defect lies at the fibrinogen-to-fibrin step or in the substrate itself. The logic is the same as any enzyme cascade: a downstream product requires every necessary upstream step.
ACTIVE PRACTICE · BLOOD PHYSIOLOGY
Keep Red-Cell Volume Fixed While Plasma Changes
The original model starts with 2.0 L packed red-cell volume and 3.0 L plasma (5.0 L blood). Assume only plasma volume changes over the short modeled period; red-cell production, destruction and size remain fixed.
Composition of blood volume:
Teal: red cells (fixed 2.0 L); gold: plasma (adjustable)
Whole blood volume: L. Hematocrit: %.
The higher fraction reflects less plasma, not increased red-cell mass.
Hematocrit is a volume fraction; it cannot by itself distinguish loss of plasma from changes in red-cell mass. The cascade is explicitly simplified, not a complete coagulation diagram or clinical diagnostic algorithm.
Check your reasoning
Choose an answer before opening its feedback.
Check 1
Red-cell volume remains unchanged while plasma volume decreases. What happens to hematocrit?
A. It increases.
Correct. The same red-cell volume occupies a larger fraction of the smaller total blood volume.
B. It must decrease.
Review this choice. The denominator decreases while the numerator stays fixed.
C. It must remain exactly unchanged.
Review this choice. Hematocrit is a volume fraction.
D. It becomes a platelet count.
Review this choice. Hematocrit specifically describes red-cell volume fraction.
Check 2
Platelet aggregation is normal, but fibrin formation is absent. Which broad process is most directly impaired?
A. Secondary hemostasis
Correct. Fibrin stabilization depends on the coagulation cascade.
B. Primary hemostasis only
Review this choice. Platelet aggregation is stated to be normal.
C. Oxygen diffusion
Review this choice. The defect concerns fibrin formation.
D. DNA replication
Review this choice. This is a hemostatic pathway problem.
Check 3
A mutation lowers erythropoietin production while red-cell destruction remains unchanged. Which long-term change is most expected?
A. Reduced erythrocyte production
Correct. Erythropoietin supports red-cell production in bone marrow.
B. Immediate conversion of plasma into red cells
Review this choice. Plasma does not directly convert into erythrocytes.
C. Increased platelet aggregation by definition
Review this choice. Erythropoietin primarily regulates erythropoiesis.
D. Elimination of all splenic macrophages
Review this choice. The stated change is reduced production signaling.
Continue learning
- Enzyme catalysis and regulation
- The cardiac cycle and circulation
- Browse Biology & Biochemistry MCAT lessons
